NEFL and Alzheimer disease: However, current biomarkers—such as the Aβ42/Aβ40 ratio, pTau181, pTau217, and NFL levels in blood (38, 39) are still far from the standard of ideal biomarkers diagnosed by AD diagnosis and deserve to be further explored.